Flo Health
Flo Health developed Flo, an AI-driven women’s health product that supports girls and women at every stage of their reproductive cycle (start of menstruation, cycle prediction, preparation for conception, pregnancy, early motherhood, and menopause).
Flo Health has raised €227M across 2 funding rounds from 3 investors, most recently a Series C round in Jul 2024. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKflo.health ↗
Total raised
€227M
€227,050,723
Funding rounds
2
Investors
3
distinct backers
Active since
2021-09
latest 2024-07
Funding by year
EUR raised per yearFlo Health — funding by year — interactive chart.
Data table
| Flo Health — funding by year | |
|---|---|
| 2021 | €42M |
| 2024 | €185M |
Signals
High confidenceRaise-next likelihood33
base rate 50% for Series C
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-30 | Series C | €185M | General Atlantic | View deal → |
| 2021-09-08 | Series B | €42M | Target Global,VNV Global | View deal → |